Azmi Nabulsi, Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 27,911 shares at $37.85 ($1.1M) on 2021-05-03, disclosed to the SEC on 2021-05-04.
Open-market sale of $1.1M PHAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.85 | 4,290 | $162K | 15.4% |
| 2 | $37.85 | 4,290 | $162K | 15.4% |
| 3 | $38.59 | 5,753 | $222K | 21.0% |
| 4 | $38.59 | 5,753 | $222K | 21.0% |
| 5 | $36.15 | 1,968 | $71K | 6.7% |
| 6 | $36.15 | 1,968 |
| $71K |
| 6.7% |
| 7 | $37.09 | 1,400 | $52K | 4.9% |
| 8 | $37.09 | 1,400 | $52K | 4.9% |
| 9 | $37.86 | 1,089 | $41K | 3.9% |
| Total | $37.84 avg | 27,911 | $1.1M | 100% |
| Filing → |
| PHAT | SELL | 2024-07-17 | $256K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $83K | — | Filing → |
| PHAT | BUY | 2022-05-16 | $163K | — | Filing → |